Study and Development of Encapsulated Forms of 4, 5′, 8-Trimethylpsoralen for Topical Drug Delivery

Drug Development Research

Volumn 61, Issue 2, 2004, Pages 86-94

  Lboutounne, H ^a   Guillaume, Y C ^a   Michel, L ^a   Makki, S ^a   Humbert, Ph ^a   Millet, J ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

4, 5 , 8 trimethylpsoralen; Liposomes; Nanospheres; Poly (D, L lactide co glycolide); Skin bioavailability

Indexed keywords

HUMAN ALBUMIN; LIPOSOME; NANOPARTICLE; POLYGLACTIN; TRIMETHYLPSORALEN;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SYNTHESIS; ENCAPSULATION; EX VIVO STUDY; HUMAN; HUMAN TISSUE; PSORIASIS; SKIN ABSORPTION; SKIN PENETRATION; SKIN SURFACE; STEADY STATE; TOPICAL DRUG ADMINISTRATION; VITILIGO;

EID: 1542283642     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10339     Document Type: Article

References (45)

1. Bangham AD, Standish MM, Watkins JC. 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
2. Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Control Rel 6:85-97.
3. Berner B, Liu P. 1995. Percutaneous penetration enhancers. Alcohols. In: Smith EW, Maibach HI, editors. Boca Raton, FL: CRC Press. p 45-60.
4. Boinpally RR, Zhou SL, Poondru S, Devraj G, Jasti BR. 2003. Lecithin vehicles for topical delivery of diclofenac. Eur J Pharm Biopharm 56:389-392.
5. Cappel MJ, Kreuter J. 1991.: Effect of nanoparticles on transdermal drug delivery. J Microencap 8:369-374.
6. Coderch L, Fonollosa J, De Pera M, Estelrich J, De La Maza A. 2000. Influence of cholesterol on liposome fluidity by EPR relationship with percutaneous absorption. J Control Rel 68: 85-95.
7. De Jalon EG, Blanco-Prierto MJ, Ygartua P, Santoyo S. 2001. Topical application of acyclovir-loaded mocroparticles: quantification of the drug in porcine skin layer. J Control Rel 75:191-197.
8. Fessi H, Puisieux F, Devissaguet JPh, Ammoury N, Benita S. 1989. Nanoparticles formation by interfacial polymer deposition following solvent displacement. Int J Pharm 55:R1-R4.
9. El Maghraby GMM, Williams AC, Barry BW. 2000. Skin delivery of estradiol from lipid vesicles: importance of liposome structure. Int J Pharm 204:159-169.
10. Gaspar MM, Blanco D, Cruz MEM, Alonso MJ. 1998. Formulation of L-asparginase-loaded PLGA nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J Control Rel 52:53-62.
11. Ghanem AH, Mahmoud H, Higuchi WI, Rohr UD, Borsadia S, Liu P, Fox JL, Good WR. 1987. The effect of ethanol on the transport of -estradiol and other permeants in hairless mousse skin II. A new quantitative approach. J Control Rel 6:75-83.
12. Golden MG, McKie JE, Potts RO. 1987. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci 1:76:25-28.
13. Goldsmith LB, Friberg SE, Wahlberg JE. 1988. The effect of solvent extraction on the lipids of the stratum corneum in relation to observed immediate whitening of the skin. Contact Dermatis 19:348-350.
14. Hadgraf J, Pugh WJ. 1988. The selection and design of topical and transdermal agents (a review). J Invest Dermatol 3:131-135.
15. Hofland HEJ, Bowstra JA, Bodde HE, Spies F, Junginger HE. 1995. Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualisation and small angle X-ray scattering studies. Br J Dermatol 32:853-866.
16. Houk J, Guy RH. 1988. Membrane models for skin penetration studies. Chem Rev 88:455-471.
17. Jenning V, Gysler A, Schäfer-Korting M, Gohla SH. 2000. Vitamin A-loaded solid lipid nanoparticles for topical use: occlusive properties and drugs targeting to the upper skin. Eur J Pharm Biopharm 49:211-218.
18. Kanikkannan N, Singh M. 2002. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248:219-228.
19. Kim J, Cho Y, Choi H. 2000. Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin. Int J Pharm 196:105-113.
20. Lademann J, Weigmann HJ, Rickmeyer C, Barthalmer H, Schaefer H, Mueller G, Sterry W. 1999. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12: 247-256.
21. Lboutounne H, Chaulet JF, Ploton C, Falson F, Pirot F. 2002. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(e-caprolactone) nanocapsule encapsulated form and as a digluconate. J Control Rel 82:319-334.
22. Fujii M, Shiozawa K, Watanabe Y, Matsumoto M. 2001. Effect of phosphatidylcholine on skin permeation of indomethacin from gel prepared with liquid paraffin and hydrogenated phospholipids. Int J Pharm 222:57-64.
23. Mezei M, Gulasekharam V. 1980a. Liposomes: a selective drug delivery system for the topical route of administration: I: lotion dosage form. Life Sci 26:1473-1477.
24. Mezei M., Gulasekharam V. 1980b. Liposomes: a selective drug delivery system for the topical route of administration: I: gel dosage form. J Pharm Pharmacol 34:473-474.
25. Müler B, Kreuter J. 1999. Enhanced transport of nanoparticle associated drugs through natural and artificial membranes, a general phenomen? Int J Pharm 178:23-32.
26. Neuman MG, Haber JA, Malkiewicz IM, Cameron RG, Katz GG, Shear NH. 2002. Ethanol signals for apoptosis in cultured skin cells. Alcohols 26:179-190.
27. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. 2001. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 219:95-105.
28. Prognon P. 1984. Contribution au métabolismes et à l'étude de la fixation sur les structures cutanées de furocoumarines photosensiblisantes. Thesis, series E, no. 194, Université Paris sud.
29. Rolland A. 1993. Particulate carriers in dermal and transdermal drug delivery. In: Pharmaceutical particulate carriers, vol. 61. New York: Marcel Dekker, Inc. p 367-421.
30. Rolland A, Wagner N, Chatelus A, Shroot B, Schaefer H. 1993. Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharm Rel 10:1738-1744.
31. Ross JS, Shah JC. 2000. Reduction in skin permeation of N,N-dimethyl-m-toluamide (DEET) by altering the skin/ vehicle partition coefficient. J Control Rel 67:211-221.
32. Saïd A, Makki S, Muret P, Rouland RC, Toubin G, Millet J. 1996. Lipophilicity determination of psoralens used in therapy through solubility and partitioning: comparison of theoretical and experimental approaches. J Pharm Sci 85:387-392.
33. Saïd A, Makki S, Muret P, Humbert P, Millet J. 1997. Psoralens percutaneous permeation across the human whole skin and the epidermidis in respect to their polarity (in vitro study). J Dermatol Sci 14:136-144.
34. Santoyo S, Ga de Jalon E, Ygartua P, Renedo MJ, Blanco-Prieto MJ. 2002.: Optimization of topical penetration using microparticles. Int J Pharm 242:107-113.
35. Schmid MH, Korting HC. 1994. Liposomes as drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst 11:97-118.
36. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery device. J Control Rel 70:1-20.
37. Stolk LML, Wersterhof W, Cormane RH, Zwieten PA. 1981. Serum and urine concentrations of 5-methoxypsoralen after oral administration. Br J Dermatol 105:415-420.
38. Thomas NT, Panchanula R. 2003. Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur J Pharm Sci 18:71-79.
39. Touitou E, Junginger HE, Weiner ND, Nagai N, Mezei M. 1994. Liposomes as carriers for topical and transdermal delivery. Int J Pharm 83:1189-1203.
40. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes: Novel vesicular for enhanced delivery: characterization and skin penetration properties. J Control Rel 65:403-418.
41. Vermeer BJ, Reman FC, Van Gent CM. 1975. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 64:190-195.
42. Wang J, Wang BM, Schwendeman SP. 2002. Characterization of the initial burst release of a model peptide from poly (D, L-lactide-co-glycolide) microspheres. J Control Rel 82:289-307.
43. Wolf M, Wirth M, Pittner F, Gabor F. 2003. Stabilisation and determination of the biological activity of L-asparaginase in poly (D, L-lactide-co-glycolide) nanospheres. Int J Pharm 256: 141-152.
44. Yokomizo Y. 1996. Effect of phosphatidylcholine on the percutaneous penetration of drugs through the dorsal skin of guinea pigs in vitro; and analysis of the molecular mechanism, using attenuated total reflectance fourier transform infrared (ATR-FTIR) spectroscopy. J Control Rel 42:249-262.
45. Zellmer S, Pfeil W, Lasch J. 1995. Interaction of phosphatidylcholine liposomes with the human stratum corneum. BBA 1237: 176-182.